ClinicalTrials.gg
Biological

Troculeucel clinical trials

Also written Natural killer cells and SNK01.

studies test it
41
open now
2
in phase 3
0
first study started
2005

How each study uses troculeucel is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the troculeucel studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

NK immunotherapy
18
High-activity natural killer
6
HANK cell
5
NK cells
2

Development codes

SNK01
5
IND 13794
1

Other names

Natural killer cells
8

Studies by the year they started

41 studies that test it; most in 2016 (25)

Studies that test troculeucel, by start year
YearStudies
20051
20081
20103
20121
20131
201625
20171
20192
20214
20231
20251

By phase

A phase 1/2 study counts in both.

Phase 1
35
Phase 2
36

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 7 · Other 34

Fuda Cancer Hospital, Guangzhou (25) · NKGen Biotech, Inc. (6) · Masonic Cancer Center, University of Minnesota (5) · Hospital de Clinicas de Porto Alegre (2) · St. Jude Children's Research Hospital (1) · Monica Thakar (1) · NKMAX Co., Ltd. (1)

Often tested with

Tested in the same studies.

Antineoplastic Agents (1) · Interleukin-2 (1) · Anti-EGFR/CD16A Bispecific Antibody AFM24 (1)

Studies

Open first, then newest update. How each study uses troculeucel is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 41

See all 41 studies that test troculeucel →

Given beside what is tested · 4 — troculeucel is usual care or a partner of the new treatment

Codes

What other systems call troculeucel · ClinicalTrials.gg INT016883

  • UNII (FDA) IZR558KO53TROCULEUCELOne source FDA
  • NCI Thesaurus C178330TroculeucelOne source FDA

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.